1. Home
  2. CR vs BIO Comparison

CR vs BIO Comparison

Compare CR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crane Company

CR

Crane Company

N/A

Current Price

$202.12

Market Cap

11.8B

Sector

Industrials

ML Signal

N/A

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$359.47

Market Cap

10.3B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CR
BIO
Founded
1855
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
10.3B
IPO Year
2022
1994

Fundamental Metrics

Financial Performance
Metric
CR
BIO
Price
$202.12
$359.47
Analyst Decision
Strong Buy
Hold
Analyst Count
10
3
Target Price
$241.40
★ $356.67
AVG Volume (30 Days)
★ 399.0K
222.7K
Earning Date
10-27-2026
11-04-2026
Dividend Yield
★ 0.49%
N/A
EPS Growth
23.96
★ 142.61
EPS
4.43
★ 11.25
Revenue
$2,305,000,000.00
★ $2,583,200,000.00
Revenue This Year
$26.35
N/A
Revenue Next Year
$6.06
$1.86
P/E Ratio
$47.28
★ $32.66
Revenue Growth
★ 8.16
0.65
52 Week Low
$159.58
$236.73
52 Week High
$230.50
$396.23

Technical Indicators

Market Signals
Indicator
CR
BIO
Relative Strength Index (RSI) 47.09 42.74
Support Level $196.65 $350.89
Resistance Level $210.63 $392.10
Average True Range (ATR) 7.24 12.70
MACD 0.10 -1.98
Stochastic Oscillator 33.99 15.43

Price Performance

Historical Comparison
CR
BIO

About CR Crane Company

Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and advanced technologies, and process flow technologies. Crane generated approximately $2.3 billion in revenue in 2025.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: